Overview
- Judge Carro announced Wednesday that Luigi Mangione’s lawyers will pursue an affirmative psychiatric defense claiming he suffered an “extreme emotional disturbance” at the time of the Dec. 4, 2024, killing of UnitedHealthcare CEO Brian Thompson.
- The judge ordered defense psychiatric records unsealed and must be turned over quickly so prosecutors can obtain their own expert evaluation before the state trial.
- Key physical evidence allowed at the state trial includes a 3D‑printed gun and a red notebook prosecutors say link Mangione to the attack, while a weapons count tied to a magazine seized in an earlier warrantless search was dismissed.
- The psychiatric defense could, if a jury accepts it, reduce a murder conviction to manslaughter or lead to psychiatric commitment instead of a standard prison term, but that option is not available in the separate federal case.
- The state trial remains set to begin with jury selection on Sept. 8 and a federal proceeding is scheduled for the fall, and the case’s high public profile, large crowdfunded support and social‑media attention raise fresh concerns about fair jury selection and trial strategy.